Aprea Therapeutics Inc. Common stockLive Price$3.84 USD
December 1, 2023, 9:40 am UTC Add to Watchlist Create Price Alert
Aprea Therapeutics Inc. Common stock (APRE) - Live Price
Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc. Common stock (APRE) is a publicly traded entity on various stock exchanges, representing ownership in the company. Founded in 2015, Aprea Therapeutics is a biopharmaceutical firm focused on developing innovative treatments for serious and often life-threatening diseases. The company's primary areas of research include oncology, inflammation, and central nervous system disorders. Its lead product candidate, ATI-001, is a potential breakthrough treatment for metastatic castration-resistant prostate cancer (mCRPC). Aprea Therapeutics' shares provide investors with an opportunity to participate in the potential success and growth of the company, as it advances its pipeline and seek to make a meaningful impact on patients' lives.
Get Aprea Therapeutics Inc. Common stock Price Change Alerts
Verdasi can notify you when APRE goes up or down. Get a text message or email when Aprea Therapeutics Inc. Common stock changes in price.Setup APRE Price Alerts
How Many People are employed by Elinx Corp.?
How much is Aprea Therapeutics Inc. Common stock stock worth?
Aprea Therapeutics Inc. Common stock (APRE) is worth $3.84 USD as of December 1, 2023, 9:40 am UTC time.
View the interactive graph to see how much Aprea Therapeutics Inc. Common stock has changed in the last hour or historically.
Keep learning about stocks:
When placing your trades, commissions can cut into your expected returns if you're not diligent about minimizing or eliminating trading fees entirely. Learn how!
Day trading has never been more accessible as a Canadian, with no minimum requirements, and the introduction of commission free trades. Learn how to day trade in Canada.